118
Views
10
CrossRef citations to date
0
Altmetric
Original

Effects of a single intratympanic gentamicin injection on Meniere's disease

, MD, , , &
Pages 61-66 | Published online: 08 Jul 2009

References

  • Lange G. The intratympanic treatment of Meniere's disease with ototoxic antibiotics. A follow-up study of 55 cases (author's transl)]. Laryngol Rhinol Otol (Stuttg) 1977; 56: 409–14
  • Rauch SD, Oas JG. Intratympanic gentamicin for treatment of intractable Meniere's disease: a preliminary report. Laryngoscope 1997; 107: 49–55
  • Toth AA, Parnes LS. Intratympanic gentamicin therapy for Meniere's disease: preliminary comparison of two regimens. J Otolaryngol 1995; 24: 340–4
  • Minor LB. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Am J Otol 1999; 20: 209–19
  • Longridge NS, Mallinson AI. Low-dose intratympanic gentamicin treatment for dizziness in Meniere's disease. J Otolaryngol 2000; 29: 35–9
  • Lange G, Maurer J, Mann W. Long-term results after interval therapy with intratympanic gentamicin for Meniere's disease. Laryngoscope 2004; 114: 102–5
  • Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol Neurotol 2004; 25: 544–52
  • Blakley BW. Update on intratympanic gentamicin for Meniere's disease. Laryngoscope 2000; 110: 236–40
  • Monsell E, cass S, Rybak L. Therapeutic use of aminoglycosides in Meniere's disease. Otolaryngol Clin North Am 1993; 26: 737–46
  • Hayashida T, Hiel H, Dulon D. Dynamic changes following combined treatment with gentamicin and ethacrynic acid with and without acoustic stimulation. Cellular uptake and functional correlates. Acta Otolaryngol 1989; 108: 404–13
  • Kaplan DM, Nedzelski JM, Chen JM, Shipp DB. Intratympanic gentamicin for the treatment of unilateral Meniere's disease. Laryngoscope 2000; 110: 1298–305
  • Martin E, Perez N. Hearing loss after intratympanic gentamicin therapy for unilateral Meniere's Disease. Otol Neurotol 2003; 24: 800–6
  • Quaranta A, Scaringi A, Aloidi A, Quaranta N, Salonna I. Intratympanic therapy for Meniere's disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol 2001; 121: 387–92
  • Tange R, Conijn E. Pattern of gentamicin-induced cochlear degeneration in the guinea pig. A morphological and electrophysiological study. Arch Otorhinolaryngol 1982; 236: 173–84
  • Chung W, Lee W, Moon S. Streptomicin perfusion through the round window in Meniere's disease. Korean J Otolaryngol 1998; 41: 725–9
  • Harner S, Driscoll C. Longterm follow up of transtympanic gentamicin for Meniere's syndrome. Otol Neurotol 2001; 22: 210–4
  • Bagger-Sjoback D, Bergenius J. Longterm follow-up of transtympanic gentamicin for Meniere's disease. Am J Otol 1990; 11: 406–10
  • Hiel H, Bennani H, Erre J. Kinetics of gentamicin in cochlear hair cells after chronic treatment. Acta Otolaryngol 1992; 112: 272–7
  • Takumida M, Wersall J. Initial changes in the sensory hair cell membrane following aminoglycoside administration in a guinea pig model. Arch Otorhinolaryngol 1989; 246: 26–31
  • Walsted A. Unpredictable hearing loss after intratympanic gentamicin treatment for vertigo. A new theory. Acta Otolaryngol 2001; 121: 42–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.